Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383976 · ClinicalTrials.gov registry record
Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 385
- Enrollment target
NCT05383976 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 385 participants.
The verdict
NCT05383976 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
The overarching goal of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, conducting, disseminating and evaluating an electronic health record-based automated identification program to target effective, culturally-sensitive CRC screening navigation to individuals who have not completed an ordered colonoscopy or fecal immunochemical test (FIT).
Interventions
- OTHER Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2022-03-29 |
| Est. Completion | 2024-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05383976
The ClinicalTrials.gov registry entry for NCT05383976 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program is the first listed.
NCT05383976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05383976 about?
NCT05383976 is a clinical study titled "Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)". The overarching goal of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, co...
What is the current status of trial NCT05383976?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2022-03-29. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT05383976?
The interventions under investigation include: Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program (OTHER).
Who is sponsoring clinical trial NCT05383976?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.